Dr. Kathryn K. Najafi-Tagol, MD

Dr. Najafi-Tagol practices at Eye Institute Of Marin in San Rafael, California.

Dr. Najafi-Tagol's NPI, 1184678112, was assigned on May 22, 2006. Dr. Najafi-Tagol graduated from David Geffen School of Medicine at UCLA in 1995. Dr. Najafi-Tagol holds California license A68850.

Dr. Najafi-Tagol's primary practice is Eye Institute of Marin, at 10 Paul Dr, San Rafael, CA 94903-2102. The practice phone is (415) 444-0300.

Dr. Najafi-Tagol's primary practice is Eye Institute Of Marin in San Rafael, California. Dr. Najafi-Tagol is also affiliated with California Pacific Medical Center Van Ness Campus. Dmand AI also links Dr. Najafi-Tagol to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Najafi-Tagol practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Najafi-Tagol's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Najafi-Tagol is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Najafi-Tagol is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Najafi-Tagol treats.

CMS data shows 5,732 Medicare services from Dr. Najafi-Tagol across 25 procedure codes in 2024, for 1,272 Medicare patients. Medicare paid $460,530 for them.

CMS counts 1,272 Medicare patients who saw Dr. Najafi-Tagol in 2024. The largest group is 75 to 84, with 566 patients. 75% of them have high cholesterol, and 59% have high blood pressure. 8% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Najafi-Tagol's median patient age at 74, with 63% women.

In 2024, Dr. Najafi-Tagol wrote 3,528 Medicare Part D claims for 760 patients. 52% of them were for generic drugs. CMS names the drug for 3,412 of them, across 26 drugs with 11 or more claims each, at $432,200 in total drug cost. In 2023, CMS named 3,142 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Najafi-Tagol for performance year 2024, reported as part of a group. Dr. Najafi-Tagol accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Najafi-Tagol as offering telehealth. CMS counts 245 procedures of cataract surgery by Dr. Najafi-Tagol, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Najafi-Tagol, published from 2013 to 2017. Dr. Najafi-Tagol's most frequent co-authors are David L. Stroman, MD, Mark S. Anderson, MD and Chirag Ramesh Patel, MD.

CMS Open Payments shows 168 general payments to Dr. Najafi-Tagol from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Novabay Pharmaceuticals, Inc. paid the most, $14,425.

Dr. Najafi-Tagol graduated from David Geffen School of Medicine at UCLA in 1995. Dr. Najafi-Tagol is a member of AAO.

Dr. Najafi-Tagol is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.